GOSS Gossamer Bio, Inc.: institutional ownership and insider trading
162 funds reported holding $102M of Gossamer Bio, Inc. in their latest 13F filings; in Q2 2026 funds net bought $33.3M, with 26 new positions and 46 funds selling out; over the last 12 months insiders bought $0 and sold $0 on the open market; over its last four quarters it reported revenue of $53.3M and net income of −$125M.
GOSS revenue and earnings
- Quarter ended Jun 30, 2026: revenue $9.24M, net income $16.9M, EPS -0.08
- Quarter ended Mar 31, 2026: revenue $17.0M, net income −$46.7M, EPS -0.20
- Quarter ended Dec 31, 2025: revenue $13.8M, net income −$47.2M, EPS -0.21
- Quarter ended Sep 30, 2025: revenue $13.3M, net income −$48.2M, EPS -0.21
Famous investors holding GOSS
- D. E. Shaw (D. E. Shaw & Co.): $6.74M, 0.0% of the portfolio
- Renaissance Technologies (Renaissance Technologies): $1.91M, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $1.22M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $395K, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $38.0K, 0.0% of the portfolio
Largest institutional holders of GOSS
- VANGUARD GROUP INC — $39.9M
- D. E. Shaw & Co., Inc. — $6.74M
- 683 Capital Management, LLC — $6.45M
- DeepCurrents Investment Group LLC — $6.03M
- Context Capital Management, LLC — $4.76M
- Worth Venture Partners, LLC — $4.12M
- AQR CAPITAL MANAGEMENT LLC — $2.57M
- GSA CAPITAL PARTNERS LLP — $2.47M
- WOLVERINE ASSET MANAGEMENT LLC — $2.12M
- RENAISSANCE TECHNOLOGIES LLC — $1.91M
Recent GOSS insider trades
- Aug 19, 2025: Milligan Sandra bought 26,050 shares ($50.0K)
5%+ owners
- 683 Capital Management, LLC: 10.0% (Schedule 13G, filed Jun 11, 2026)
- Context Capital Management, LLC: 9.9% (Schedule 13G, filed Jun 9, 2026)
- DeepCurrents Investment Group LLC: 7.7% (Schedule 13G, filed Jun 11, 2026)
- D. E. Shaw & Co., L.P.: 7.1% (Schedule 13D/A, filed Jul 24, 2026)
- D. E. Shaw & Co., L.L.C.: 6.0% (Schedule 13D/A, filed Aug 24, 2026)
- Opaleye Management Inc.: 5.1% (Schedule 13G, filed Jul 29, 2026)
Who owns the most GOSS stock?
The largest institutional holders of Gossamer Bio, Inc. in the latest 13F filings are VANGUARD GROUP INC ($39.9M), D. E. Shaw & Co., Inc. ($6.74M), 683 Capital Management, LLC ($6.45M).
Are insiders buying or selling GOSS?
No open-market insider buys or sells of Gossamer Bio, Inc. were reported in the last 12 months.
Which famous investors own GOSS?
D. E. Shaw, Renaissance Technologies, Two Sigma, Izzy Englander, Ken Griffin.
What was GOSS's revenue last quarter?
Gossamer Bio, Inc. reported revenue of $9.24M for the quarter ended June 30, 2026, with net income of $16.9M.